香港医思医疗集团(02138.HK)拟配发480.54万股股份
格隆汇 9 月 24日丨香港医思医疗集团(02138.HK)发布公告,2020年9月24日,认购方与公司订立签署认购协议,据此,公司已有条件同意配发及发行480.54万股每股认购价为4.25港元的认购股份。认购方应付的总代价为2040万港元。
每股认购股份的认购价4.25港元较收市价每股4.55港元折让约6.59%。认购股份占于该公告日期公司现有已发行股本约0.469%,并占紧认购股份发行后公司的经扩大已发行股本约0.466%。公司将向联交所申请批准认购股份上市及允许进行买卖。
根据披露,认购方Renaissance City Development Company Limited,是于香港注册成立的有限公司及冠君产业信托(02778.HK)的全资附属公司。其主要业务为物业投资,与冠君产业信托的另一间附属公司(作为若干单位的业主)已分别与公司的两家附属公司(作为朗豪坊办公大楼物业的租户)签订了若干租赁协议。认购事项所得款项约为2040万港元,已与租赁款项作抵销。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.